Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D000526:Alprenolol / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D001682:Biological Availability; D001702:Biopharmaceutics; D001711:Biotransformation; D001794:Blood Pressure / Q000187:drug effects; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D005082:Physical Exertion; D011412:Propanolamines / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D010647:Phenyl Ethers; D011412:Propanolamines; D000526:Alprenolol